Toleranzia AB - ESG Rating & Company Profile powered by AI
The webpage displays a free Sustainability report for Toleranzia AB. Check the bottom of this webpage for potential risks for Toleranzia AB based on industry, location and size. This Disclosure rating covers 17 UN SDGs including: 'Zero Hunger', 'Industry, Innovation & Infrastructure' and 'Life below Water'.
Toleranzia AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 0.0, social score of 5.3 and governance score of 5.3.
3.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1144 | Veerhealth Care Ltd | 3.6 | Medium |
| 1144 | iStreet Network Ltd | 3.6 | Medium |
| 1186 | Toleranzia AB | 3.5 | Medium |
| 1186 | CRISPR Therapeutics AG | 3.5 | Medium |
| 1186 | Catalent Inc | 3.5 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Toleranzia AB have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Toleranzia AB disclose current and historical energy intensity?
Sign up for free to unlockDoes Toleranzia AB report the average age of the workforce?
Sign up for free to unlockDoes Toleranzia AB reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Toleranzia AB disclose its ethnicity pay gap?
Sign up for free to unlockDoes Toleranzia AB disclose cybersecurity risks?
Sign up for free to unlockDoes Toleranzia AB offer flexible work?
Sign up for free to unlockDoes Toleranzia AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Toleranzia AB disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Toleranzia AB conduct supply chain audits?
Sign up for free to unlockDoes Toleranzia AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Toleranzia AB conduct 360 degree staff reviews?
Sign up for free to unlockDoes Toleranzia AB disclose the individual responsible for D&I?
Sign up for free to unlockDoes Toleranzia AB disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Toleranzia AB disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Toleranzia AB disclose water use targets?
Sign up for free to unlockDoes Toleranzia AB have careers partnerships with academic institutions?
Sign up for free to unlockDid Toleranzia AB have a product recall in the last two years?
Sign up for free to unlockDoes Toleranzia AB disclose incidents of discrimination?
Sign up for free to unlockDoes Toleranzia AB allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Toleranzia AB issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Toleranzia AB disclose parental leave metrics?
Sign up for free to unlockDoes Toleranzia AB disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Toleranzia AB disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Toleranzia AB disclose the pay ratio of women to men?
Sign up for free to unlockDoes Toleranzia AB support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Toleranzia AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Toleranzia AB reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Toleranzia AB involved in embryonic stem cell research?
Sign up for free to unlockDoes Toleranzia AB disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Toleranzia AB disclose its waste policy?
Sign up for free to unlockDoes Toleranzia AB report according to TCFD requirements?
Sign up for free to unlockDoes Toleranzia AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Toleranzia AB disclose energy use targets?
Sign up for free to unlockDoes Toleranzia AB disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Toleranzia AB have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Toleranzia AB
These potential risks are based on the size, segment and geographies of the company.
Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also intends to develop TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. In addition, the company develops tolerogens technology, a treatment method that creates disease-specific tolerance in the immune system for treating various autoimmune diseases. The company was founded in 2011 and is headquartered in Gothenburg, Sweden.